Meanwhile, the Bermudian’s net earned premiums (NEP) rose nearly 10% to almost $3.9bn in H1 of 2023. The company said the NEP expansion reflected 6% growth in P&C, 7% in specialty lines and 21% in life and health.
In
PartnerRe H1 non-life CoR ticks up 1.6 points to 83.5% as NEP rises 10%
